HUP0003330A2 - Tizoxanidot és nitazoxanidot tartalmazó gyógyszerkészítmények - Google Patents

Tizoxanidot és nitazoxanidot tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0003330A2
HUP0003330A2 HU0003330A HUP0003330A HUP0003330A2 HU P0003330 A2 HUP0003330 A2 HU P0003330A2 HU 0003330 A HU0003330 A HU 0003330A HU P0003330 A HUP0003330 A HU P0003330A HU P0003330 A2 HUP0003330 A2 HU P0003330A2
Authority
HU
Hungary
Prior art keywords
tizoxanide
nitazoxanide
pharmaceutical compositions
compositions containing
compound
Prior art date
Application number
HU0003330A
Other languages
English (en)
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Laboratories, L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0003330(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Laboratories, L.C. filed Critical Romark Laboratories, L.C.
Publication of HUP0003330A2 publication Critical patent/HUP0003330A2/hu
Publication of HUP0003330A3 publication Critical patent/HUP0003330A3/hu
Publication of HU229641B1 publication Critical patent/HU229641B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya olyan gyógyszerkészítmény, amely hatóanyagként az(I) képletű és a (II) képletű vegyület által alkotott csoportból kiválasztottlegalább egy vegyület tartalmaz. A hatóanyag előnyösen részecskékformájában van jelen, amelyeknek részecskemérete kisebb, mint 200 m ésaz átlagos részecskeméret nagyobb, mint 10 m, és a készítmény legalábbegy gyógyszerészetileg elfogadható savat is tartalmazhat. Ó
HU0003330A 1997-05-07 1998-05-06 Pharmaceutical compositions containing tizoxanide and nitazoxanide HU229641B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (3)

Publication Number Publication Date
HUP0003330A2 true HUP0003330A2 (hu) 2001-05-28
HUP0003330A3 HUP0003330A3 (en) 2002-10-28
HU229641B1 HU229641B1 (en) 2014-03-28

Family

ID=27420362

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003330A HU229641B1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions containing tizoxanide and nitazoxanide

Country Status (35)

Country Link
EP (2) EP1222921B1 (hu)
JP (1) JP3739802B2 (hu)
KR (2) KR100426657B1 (hu)
CN (2) CN1158074C (hu)
AP (1) AP1103A (hu)
AR (1) AR057242A2 (hu)
AT (2) ATE281166T1 (hu)
AU (1) AU740022B2 (hu)
BG (2) BG109365A (hu)
BR (1) BR9808722A (hu)
CA (2) CA2418634C (hu)
CZ (2) CZ298269B6 (hu)
DE (2) DE69827417T2 (hu)
DK (2) DK1222921T3 (hu)
EA (2) EA002920B1 (hu)
EE (1) EE04870B1 (hu)
ES (2) ES2232687T3 (hu)
GE (1) GEP20032970B (hu)
HK (1) HK1025907A1 (hu)
HU (1) HU229641B1 (hu)
IL (2) IL155799A (hu)
IS (1) IS2087B (hu)
LV (1) LV12492B (hu)
ME (1) ME00530B (hu)
NO (2) NO313983B1 (hu)
NZ (2) NZ500149A (hu)
OA (1) OA11169A (hu)
PL (1) PL193275B1 (hu)
PT (2) PT1222921E (hu)
RO (1) RO120605B1 (hu)
SI (1) SI20149B (hu)
SK (2) SK283947B6 (hu)
TR (1) TR199902733T2 (hu)
UA (2) UA57079C2 (hu)
WO (1) WO1998050035A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
CA2636527C (en) 2006-01-09 2016-05-17 Romark Laboratories, L.C. Viral hepatitis treatment
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
PE20121118A1 (es) 2009-05-12 2012-09-05 Romark Lab Lc Compuestos de haloalquil heteroaril benzamida
EP2445349B1 (en) 2009-06-26 2022-02-09 Romark Laboratories, L.C. Compounds and methods for treating influenza
US9498441B2 (en) 2012-01-27 2016-11-22 Siegfried Rhein S.A. De C.V. Nitazoxadine composition and process to prepare same
AU2015346413B2 (en) * 2014-11-11 2019-08-29 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
EP4146664A2 (en) 2020-05-01 2023-03-15 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
KR20040004544A (ko) 2004-01-13
UA57079C2 (uk) 2003-06-16
AU740022B2 (en) 2001-10-25
KR100576646B1 (ko) 2006-05-08
NO335781B1 (no) 2015-02-16
HK1025907A1 (en) 2000-12-01
DE69809928T2 (de) 2003-04-24
SK283947B6 (sk) 2004-05-04
EP1005342A4 (en) 2001-02-07
UA74388C2 (uk) 2005-12-15
GEP20032970B (en) 2003-05-27
IL155799A (en) 2004-08-31
SI20149B (en) 2001-08-31
NO20021832L (no) 2000-01-04
AU7289598A (en) 1998-11-27
NO20021832D0 (no) 2002-04-18
BR9808722A (pt) 2000-07-11
CA2288003A1 (en) 1998-11-12
CZ298270B6 (cs) 2007-08-08
IL155799A0 (en) 2003-12-23
JP2001503067A (ja) 2001-03-06
CA2418634A1 (en) 1998-11-12
CZ391199A3 (cs) 2000-07-12
SK283946B6 (sk) 2004-05-04
EA199901012A1 (ru) 2000-08-28
OA11169A (en) 2003-04-25
KR100426657B1 (ko) 2004-04-13
DE69809928D1 (de) 2003-01-16
ES2150404T3 (es) 2003-07-01
CN1255060A (zh) 2000-05-31
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
CN1552322A (zh) 2004-12-08
NO995406D0 (no) 1999-11-04
CN100515420C (zh) 2009-07-22
NZ500149A (en) 2001-11-30
AP1103A (en) 2002-09-04
EP1222921A1 (en) 2002-07-17
EA002920B1 (ru) 2002-10-31
BG109365A (en) 2006-08-31
SI20149A (sl) 2000-08-31
BG64973B1 (bg) 2006-11-30
PT1005342E (pt) 2003-02-28
DE69827417D1 (de) 2004-12-09
PT1222921E (pt) 2005-02-28
DK1005342T3 (da) 2003-03-24
CZ298269B6 (cs) 2007-08-08
TR199902733T2 (xx) 2000-03-21
EP1222921B1 (en) 2004-11-03
SK151199A3 (en) 2000-07-11
ES2232687T3 (es) 2005-06-01
CA2288003C (en) 2003-10-21
LV12492B (en) 2001-01-20
DE69827417T2 (de) 2005-10-27
WO1998050035A1 (en) 1998-11-12
NZ513881A (en) 2002-10-25
EE04870B1 (et) 2007-08-15
EA200100956A1 (ru) 2002-02-28
NO995406L (no) 2000-01-04
EP1005342B1 (en) 2002-12-04
IL132516A (en) 2003-12-10
ES2150404T1 (es) 2000-12-01
IL132516A0 (en) 2001-03-19
RO120605B1 (ro) 2006-05-30
IS5223A (is) 1999-10-19
CN1158074C (zh) 2004-07-21
JP3739802B2 (ja) 2006-01-25
ATE228839T1 (de) 2002-12-15
IS2087B (is) 2006-03-15
AR057242A2 (es) 2007-11-21
KR20010020322A (ko) 2001-03-15
BG103958A (en) 2000-07-31
HUP0003330A3 (en) 2002-10-28
NO313983B1 (no) 2003-01-13
HU229641B1 (en) 2014-03-28
EA002908B1 (ru) 2002-10-31
EP1005342A1 (en) 2000-06-07
EE9900578A (et) 2000-08-15
LV12492A (en) 2000-06-20
PL336805A1 (en) 2000-07-17
ME00530B (me) 2011-10-10
PL193275B1 (pl) 2007-01-31
ATE281166T1 (de) 2004-11-15
DK1222921T3 (da) 2005-03-07

Similar Documents

Publication Publication Date Title
HUP9801615A2 (hu) Szimetikon/vízmentes kalcium-foszfát-kompozíciók
CA2329005A1 (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
AU3912493A (en) A pharmaceutical composition containing a defined lipid system
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
CA2370565A1 (en) Dermally applicable vitamin d-containing pharmaceutical compositions
HUP0301851A2 (hu) Javított diszpergálhatóságú szárazpor-összetételek
HUP0301972A2 (hu) Fentanilszerű szerkezetű opioidot és ketamint tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmény
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
CA2346001A1 (en) Controlled release nanoparticulate compositions
CA2326756A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients
CA2358062A1 (en) Controlled release galantamine composition
CA2182582A1 (en) Compositions containing micronized nebivolol
AU2323897A (en) Cyclopropyl alkanoic acid derivatives
DK0642344T3 (da) Stabilt tørt pulver af hydratiseret cephalosporin til oral suspensionsformulering.
AU2002221702A1 (en) Pharmaceutical compositions
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
CA2343732A1 (en) Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto
HUP0003330A2 (hu) Tizoxanidot és nitazoxanidot tartalmazó gyógyszerkészítmények
HUP0001780A2 (hu) Stabilizált tibolont tartalmazó készítmények és eljárás előállításukra
CA2120048A1 (en) Pharmaceutical composition having analgesic activity
CA2318260A1 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
BG104596A (en) Pahrmaceutical compositions containing micronized bicyclic drugs
AU6505294A (en) New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use
HUP0300557A2 (hu) N-dezacetiltiokolkicin-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények
CA2344470A1 (en) Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees